Endovascular Aneurysm Repair: Is Imaging Surveillance Robust, and Does It Influence Long-term Mortality?
- 277 Downloads
Endovascular aneurysm repair (EVAR) is the dominant treatment strategy for abdominal aortic aneurysms. However, as a result of uncertainty regarding long-term durability, an ongoing imaging surveillance program is required. The aim of the study was to assess EVAR surveillance in Scotland and its effect on all-cause and aneurysm-related mortality.
A retrospective analysis of all EVAR procedures carried out in the four main Scottish vascular units. The primary outcome measure was the implementation of post-EVAR imaging surveillance across Scotland. Patients were identified locally and then categorized as having complete, incomplete, or no surveillance. Secondary outcome measures were all-cause mortality and aneurysm-related mortality. Cause of death was obtained from death certificates.
Data were available for 569 patients from the years 2001 to 2012. All centers had data for a minimum of 5 contiguous years. Surveillance ranged from 1.66 to 4.55 years (median 3.03 years). Overall, 53 % had complete imaging surveillance, 43 % incomplete, and 4 % none. For the whole cohort, all-cause 5-year mortality was 33.5 % (95 % confidence interval 28.0–38.6) and aneurysm-related mortality was 4.5 % (.8–7.3). All-cause mortality in patients with complete, incomplete, and no imaging was 49.9 % (39.2–58.6), 19.1 % (12.6–25.2), and 47.2 % (17.7–66.2), respectively. Aneurysm-related mortality was 3.7 % (1.8–7.4), 4.4 % (2.2–8.9), and 9.5 % (2.5–33.0), respectively. All-cause mortality was significantly higher in patients with complete compared to incomplete imaging surveillance (p < 0.001). No significant differences were observed in aneurysm-related mortality (p = 0.2).
Only half of EVAR patients underwent complete long-term imaging surveillance. However, incomplete imaging could not be linked to any increase in mortality. Further work is required to establish the role and deliverability of EVAR imaging surveillance.
KeywordsAAA EVAR Mortality Surveillance
Funded by an Endowment fund from the Glasgow and Clyde hospitals, Scotland. No support was provided by pharmaceutical or medical-device companies. The authors acknowledge the support provided by Andrew Tambyraja, vascular surgeon, NHS Grampian, Aberdeen Royal Infirmary, Aberdeen, Scotland, United Kingdom, for facilitating assess to relevant databases at their local vascular unit. Statistical analysis was performed by C.W.
Conflict of interest
C.W. received financial support from an Endowment fund from the Greater Glasgow and Clyde hospitals, Scotland, during the conduct of the study. The other authors declare that they have no conflict of interest.
- 1.National Institute for Health and Clinical Excellence (2009) Endovascular stent-grafts for the treatment of abdominal aortic aneurysms. National Institute for Health and Clinical Excellence (NICE), London. http://www.guideline.gov/content.aspx?id=14447
- 8.Thomas SM, Beard JD, Ireland M, Ayers S, Vascular Society of Great Britain and Ireland and the British Society of Interventional Radiology (2005) Results from the Prospective Registry of Endovascular Treatment of Abdominal Aortic Aneurysms (RETA): mid-term results to five years. Eur J Vasc Endovasc Surg 29:563–570PubMedCrossRefGoogle Scholar